Richard A. Van Etten

About Richard A. Van Etten

Richard A. Van Etten, With an exceptional h-index of 66 and a recent h-index of 33 (since 2020), a distinguished researcher at University of California, Irvine, specializes in the field of Cancer Research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease

Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy

A prospective clinical trial to evaluate the performance of a multi-analyte blood test for early detection of hepatocellular carcinoma among at-risk patients with liver …

1668. The SAFER Lines Project: A Mobile-App Strategy for Prevention of Outpatient Central Line Associated Bloodstream Infection (CLABSI)

Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies

A multi‐analyte cell‐free DNA–based blood test for early detection of hepatocellular carcinoma

The impact of Rhodiola rosea on biomarkers of diabetes, inflammation, and microbiota in a leptin receptor-knockout mouse model

Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021

Richard A. Van Etten Information

University

Position

Professor of Medicine

Citations(all)

26628

Citations(since 2020)

4034

Cited By

24072

hIndex(all)

66

hIndex(since 2020)

33

i10Index(all)

117

i10Index(since 2020)

67

Email

University Profile Page

Google Scholar

Richard A. Van Etten Skills & Research Interests

Cancer Research

Top articles of Richard A. Van Etten

Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease

Blood

2023/11/28

Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy

Elife

2023/4/28

A prospective clinical trial to evaluate the performance of a multi-analyte blood test for early detection of hepatocellular carcinoma among at-risk patients with liver …

2023/2/1

1668. The SAFER Lines Project: A Mobile-App Strategy for Prevention of Outpatient Central Line Associated Bloodstream Infection (CLABSI)

Open Forum Infectious Diseases

2022/12/1

Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies

2022/10

A multi‐analyte cell‐free DNA–based blood test for early detection of hepatocellular carcinoma

Hepatology communications

2022/7

The impact of Rhodiola rosea on biomarkers of diabetes, inflammation, and microbiota in a leptin receptor-knockout mouse model

Scientific reports

2022/6/22

Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021

haematologica

2021/7/7

Optimal experimental design for mathematical models of haematopoiesis

Journal of the Royal Society Interface

2021/1/27

Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies

2020/12

Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia

Leukemia

2020/8

Cellular and molecular biology of chronic myeloid leukemia

U: UpToDate, Larson RA ed. UpToDate [Internet]. Waltham, MA: UpToDate

2020

See List of Professors in Richard A. Van Etten University(University of California, Irvine)